


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.47%
-1.05%
+11.75%
+15.45%
NUVB
Nuvation Bio Inc.
$5.84
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
NUVB Price Performance
$5.9 (-1.02%)
$8.31 (-29.72%)
$3.67 (+59.13%)
$1.98 (+194.95%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
NUVB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NUVB Street Sentiment is bullish and have positive views on the near-term outlook
NUVB has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Jan 30, 2026
Reiterate
Buy
Jan 08, 2026
Initiate
Neutral
UBS
Dec 15, 2025
Upgrade
Buy
Zacks
Dec 11, 2025
Reiterate
Buy
HC Wainwright & Co.
Dec 01, 2025
Reiterate
Buy
HC Wainwright & Co.
What is NUVB current stock price?
What are NUVB stock strengths?
What is NUVB Risk Level?
What is NUVB market cap and volume?
What is NUVB current Stock IQ?
Should I buy NUVB stock right now?
Is NUVB a Strong Buy right now?
What does a 'Strong Buy' rating mean for NUVB?
What does a 'Strong Sell' rating mean for NUVB?
What factors influence NUVB's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
NUVB
Nuvation Bio Inc.
Current Price
$5.84

NUVB Price Performance
$5.9 (-1.02%)
$8.31 (-29.72%)
$3.67 (+59.13%)
$1.98 (+194.95%)
NUVB Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
NUVB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NUVB Street Sentiment is bullish and have positive views on the near-term outlook
NUVB has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
NUVB Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
NUVB Latest Analysis
Nuvation Bio Inc. (NUVB) Reports Q4 Loss Beats Revenue Estimates. Nuvation Bio (NUVB) delivered earnings and revenue surprises of -2.33% and 52.63% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Today
Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma. Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9 Nuvation Bio Inc. (NYSE:NUVB) finalized a protocol amendment to an ongoing global SIGMA study of safusidenib. The company is evaluating the efficacy and safety of safusidenib in patients with high-risk or high-grade IDH1-mutant astrocytoma. The amended protocol [….]
Today
Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?. Nuvation Bio Inc. (NYSE:NUVB) is one of the best small-cap stocks with huge growth potential. Nuvation Bio Inc. (NYSE:NUVB) announced on February 9 the finalization of a protocol amendment to the ongoing global SIGMA study of safusidenib that expands it to a Phase 3 trial. Safusidenib is a novel oral potent brain-penetrant targeted inhibitor of mutant [….]
Fri Feb 27, 2026
RSI Alert: Nuvation Bio (NUVB) Now Oversold. Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Feb 11, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NUVB Stock trends
NUVB Stock performance
NUVB Stock analysis
NUVB investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.